Number of Shares
33,616.00
Current Holdings Value*
$3.01 Mil
% of Portfolio
0.78%
Total Estimate Gain
$1.50 Mil
% of Total Estimate Gain
19.11%

Goldman Sachs Small Cap Equity Insights Fund's Blueprint Medicines Corp Holding Summary

As of 2025-04-30, GOLDMAN SACHS TRUST held 33,616.00 shares of Blueprint Medicines Corp(BPMC), totaling $3.01 Mil. This investment constitutes 0.78% of their stock portfolio, and GOLDMAN SACHS TRUST now holds 0.05% of the outstanding Blueprint Medicines Corp(BPMC) stock.

The initial trade took place in 2019Q4. And since then Goldman Sachs Small Cap Equity Insights Fund has made 6 purchases of BPMC, at an average price of $82.15, for a total of 95,632.00 shares. In addition, there have been 5 sales at an average price of $80.72 for 62,016.00 shares. Based on historical transaction data and BPMC's current price of $129.46, Goldman Sachs Small Cap Equity Insights Fund's estimated gain on his BPMC holdings is $1.50 Mil, reflecting a 19.11% gain to date.

Goldman Sachs Small Cap Equity Insights Fund BPMC ($129.46) Holding Chart

Goldman Sachs Small Cap Equity Insights Fund BPMC ($129.46) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1